当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Top ten research priorities for type 2 diabetes: results from the Diabetes UK–James Lind Alliance Priority Setting Partnership
The Lancet Diabetes & Endocrinology ( IF 44.5 ) Pub Date : 2017-10-29 , DOI: 10.1016/s2213-8587(17)30324-8
Sarah Finer , Paul Robb , Katherine Cowan , Ann Daly , Elizabeth Robertson , Andrew Farmer

About 20% of the UK population are living with, or are at risk of, type 2 diabetes, with estimated annual National Health Service treatment costs of £8·8 billion.1 This rising tide identifies an urgent need to reduce uncertainties around the causes, prevention, and treatment of type 2 diabetes. A patient-centred approach is a cornerstone of high-quality diabetes care and is mirrored in research by an increasing focus on patient and public involvement.2 The James Lind Alliance has a 13-year history of collaboration with patients, carers, and clinicians in identifying and prioritising unmet research needs to drive improvements in clinical care.

中文翻译:

2型糖尿病的十大研究重点:英国糖尿病协会-詹姆斯·林德联盟优先制定合作伙伴关系的结果

英国约有20%的人口患有2型糖尿病,或有患2型糖尿病的风险,据估计National Health Service每年的治疗费用为8·80亿英镑。1这种上升趋势表明,迫切需要减少2型糖尿病的病因,预防和治疗方面的不确定性。以患者为中心的方法是高质量糖尿病护理的基石,并且在研究中反映出对患者和公众参与的日益关注。2詹姆斯·林德联盟(James Lind Alliance)在与患者,护理人员和临床医生合作方面已有13年的历史,用于确定和优先满足未满足的研究需求以推动临床护理的改善。
更新日期:2017-10-30
down
wechat
bug